Is it the adenovirus vaccine technology, used by AstraZeneca and Johnson & Johnson, causing blood clots? There's no evidence yet
- Written by Kylie Quinn, Vice-Chancellor's Research Fellow, School of Health and Biomedical Sciences, RMIT University
This week, US health authorities recommended pausing the rollout of the one-shot Johnson & Johnson/Janssen COVID-19 vaccine while investigations into exceptionally rare blood clots take place.
Six women suffered blood clots out of nearly seven million doses administered.
The J&J vaccine uses broadly similar vaccine technology as the...





